Previous studies have demonstrated that CTRP3 is an endogenous antagonist of lipopolysaccharide [19] and that aberrant CTRP3 expression is related to multiple types of human disorders, such as arthritis [20], sepsis [21] and myocardiac dysfunction [22]. The gene discussed is C1QTNF3; the disease is arthritic joint disease.